メインコンテンツにスキップ
ホーム / コンテンツ / イベント / 2022 World Evidence, Pricing and Access Congress – Stand 14

2022 World Evidence, Pricing and Access Congress – Stand 14

2022 World Evidence, Pricing and Access Congress – Stand 14
Speaking Engagements
2022 World Evidence, Pricing and Access Congress – Stand 14
Roundtable: The New Normal - Pioneering Digital Stakeholder Engagement in Pharma and Biotech
Shawn Bates, VP, Global Portfolio Leader, Certara l Christian Pichardo, Consultant, Certara l Jenifer O’Neill, Merck |
2022 World Evidence, Pricing and Access Congress – Stand 14
Morning Plenary: Driving access to rare disease treatments in Europe
Pascaline Faivre | Senior Director Market Access, Certara
2022 World Evidence, Pricing and Access Congress – Stand 14
Roundtable: Access to rare disease treatments in Europe: challenges and opportunities
Elvira Mueller, VP, HTA and Evidence Development, Certara l Sanja Stanisic, Associate Director, Certara |
Powered by Translations.com GlobalLink OneLink Software